Thermo Fisher Scientific Sails Through Q3 With Mixed Earnings, CEO Says In Great Position To Deliver 2024 Objectives
Portfolio Pulse from Vandana Singh
Thermo Fisher Scientific reported mixed Q3 earnings with revenue slightly below expectations but EPS beating consensus. The company reaffirmed its 2024 sales guidance and slightly revised its EPS guidance. Despite the mixed results, the CEO expressed confidence in meeting 2024 objectives. TMO stock fell by 2.17% following the announcement.
October 23, 2024 | 1:43 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Thermo Fisher Scientific's Q3 earnings were mixed, with revenue slightly below expectations but EPS beating consensus. The company reaffirmed its 2024 sales guidance and slightly revised its EPS guidance. Despite the mixed results, the CEO expressed confidence in meeting 2024 objectives. TMO stock fell by 2.17% following the announcement.
Thermo Fisher's Q3 revenue was slightly below expectations, which can negatively impact investor sentiment. However, the EPS beat and reaffirmed guidance provide some positive outlook. The immediate market reaction was a 2.17% drop in stock price, indicating a short-term negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100